Old dye gets new shot at fighting tough cancer
NCT ID NCT07435415
Summary
This early safety study is testing whether injecting a blue dye called methylene blue directly into tumors can make radiation therapy more effective for head and neck cancer that has come back after previous radiation. Ten patients will receive weekly injections along with six weeks of radiation to see if the combination is safe and shows promise. The goal is to find a new way to control this difficult-to-treat recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China medical university hospital
Taichung, Taiwan, 404, Taiwan
Conditions
Explore the condition pages connected to this study.